Multiplex PCR Serotyping of Campylobacter jejuni
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for differentiating Campylobacter jejuni strains, such as Penner serotyping, are technically difficult, expensive, and prone to errors due to phase variation and slip-strand mutations, limiting their widespread use and accuracy.
Innovation Solution
A molecular method using multiplex DNA primers for PCR amplification of specific capsule/Penner types, which is more standardized, cost-effective, and not affected by capsule expression phase variation, allowing for the identification of 23 serotypes without the need for type antisera production.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If Penner serotyping is used for strain differentiation, then serotype identification can be achieved, but the method is technically difficult and expensive
Solution Approach 1:
The patent replaces the mechanical/chemical serotyping system with a molecular biology system. Instead of using antisera and hemagglutination assays, the invention uses PCR amplification with specific primers to detect capsule type-specific DNA sequences, thereby substituting a complex immunological method with a more standardized molecular method
Solution Approach 2:
The invention creates DNA copies of capsule type-specific sequences through PCR amplification. By amplifying specific genomic regions that encode capsule polysaccharide synthesis enzymes, the method generates detectable copies of type-specific genetic information, enabling identification without needing the actual capsule antigens or antisera
2Measurement precision
If Penner serotyping is used for strain differentiation, then serotype identification can be achieved, but it is expensive to produce type antisera
Solution Approach 1:
The patent replaces expensive, complex antisera with inexpensive synthetic DNA primers. These primers can be easily synthesized in large quantities at low cost and do not require animal immunization or purification processes, making the reagents both cheaper and more stable
Solution Approach 2:
The invention substitutes the expensive immunological reagents (antisera) with molecular biology reagents (PCR primers and polymerase). This replacement eliminates the need for animal-based antisera production while achieving the same diagnostic goal through detection of type-specific DNA sequences
3Measurement precision
If Penner serotyping is used for strain differentiation, then serotype identification can be achieved, but it is prone to errors due to phase variation and slip-strand mutations
Solution Approach 1:
The patent detects the genetic potential for capsule type production before the capsule is actually expressed. By amplifying DNA sequences that encode capsule synthesis enzymes, the method identifies the serotype based on genetic information that is stable and not subject to phase variation, thereby performing the identification action before the problematic capsule expression occurs
Solution Approach 2:
The invention replaces the serological detection system (which detects expressed capsule antigens) with a molecular detection system (which detects genetic sequences). This substitution moves the detection target from the phenotypic level (capsule expression) to the genotypic level (DNA sequences), eliminating errors caused by phase variation and mutations that affect capsule production
4Measurement precision
If traditional serotyping methods are used, then serotype identification can be performed, but the number of reactions required is large
Solution Approach 1:
The patent combines multiple serotype-specific primer pairs into a single multiplex PCR reaction. By designing primers with different melting temperatures and amplification efficiencies, the method can simultaneously amplify multiple type-specific DNA sequences in one reaction, thereby merging what would traditionally require multiple separate assays into a single integrated test
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach simplifies the identification of Campylobacter jejuni serotypes, reduces the number of reactions required, and is more reliable than traditional serotyping methods, enabling broader accessibility and accuracy in strain differentiation.
Implementation Method 1
a method of amplifying a capsule locus of a Campylobacter jejuni strain comprising: providing a multiplex PCR amplification reaction mix comprising: a forward primer and a reverse primer
Data Source
AI summary
The inventive method and associated reagents relate to a molecular approach to determining Campylobacter jejuni capsule/Penner types. The invention also relates to a method of identifying Campylobacter jejuni types using primers in a multiplex PCR assay.